Table 2.
Percentage differences between observed and predicted number of urological procedures in Australia during the first wave of the COVID-19 pandemic.
| Procedure | Percentage difference (95% CI) |
|||||
|---|---|---|---|---|---|---|
| Jan 2020 | Feb 2020 | Mar 2020 | Apr 2020 | May 2020 | Jun 2020 | |
| Oncological procedures | ||||||
| Radical prostatectomy | 9.8 (−6.8, 33.5) | −2.8 (−15.6, 14.6) | −7.5 (−18.9, 7.6) | −10.2 (−22.7, 7.3) | −13.2 (−23.6, 0.4) | 16.9a (0.9, 39.0) |
| Nephrectomy + nephroureterectomy | 21.9 (−0.8, 57.9) | 19.3 (−0.6, 49.1) | 6.1 (−11.4, 32.0) | −2.6 (−17.9, 19.7) | −33.6a (−43.8, −19.1) | −4.2 (−17.7, 14.6) |
| Cystectomy | −15.0 (−34.9, 22.5) | 11.9 (−12.8, 56.0) | −2.2 (−23.4, 35.1) | 3.0 (−18.9, 41.0) | −13.0 (−29.9, 14.7) | 6.2 (−16.0, 44.2) |
| Transurethral resection of bladder tumour | −4.4 (−16.4, 11.7) | −2.1 (−12.1, 10.5) | −4.6 (−13.8, 6.7) | −24.1a (−32.3, −13.7) | −36.7a (−42.3, −29.8) | −0.6 (−10.8, 12.4) |
| Diagnostic procedures | ||||||
| Biopsies of upper tract or bladder | −1.0 (−11.4, 12.2) | 4.5 (−4.9, 16.1) | −4.3 (−12.4, 5.5) | −9.4 (−18.1, 1.3) | −25.6a (−31.6, −18.5) | 2.1 (−7.5, 13.8) |
| Cystoscopy | −0.4 (−9.8, 11.3) | 7.9 (−0.4, 17.7) | −4.3 (−11.2, 3.9) | −40.3a (−45.3, −34.4) | −40.0a (−44.0, −35.3) | −3.4 (−10.7, 5.2) |
| Transperineal biopsy | 10.6 (−4.5, 31.4) | 6.8 (−6.9, 25.3) | 3.0 (−10.0, 20.2) | −13.4 (−26.6, 5.6) | −27.5a (−37.2, −14.1) | −11.6 (−25.1, 7.8) |
| Non-Oncological procedures | ||||||
| Stone surgeries | 2.2 (−10.8, 19.8) | −0.1 (−10.9, 13.7) | −8.2 (−17.3, 3.2) | −6.1 (−17.0, 8.0) | −32.9a (−39.4, −24.9) | −7.3 (−17.6, 6.0) |
| Endoscopic procedures for benign prostatic hyperplasia | 2.7 (−8.5, 17.1) | 3.5 (−6.0, 15.1) | 3.4 (−5.8, 14.7) | −26.8a (−34.2, −17.5) | −42.4a (−46.9, −37.0) | −10.6a (−18.5, −1.0) |
CI, confidence interval; COVID-19, coronavirus disease 2019.
a
Indicates statistical significance (p<0.05).